Facts
- HQ
- Bellevue, Washington, US
- Sectors
- Wellness and Fitness Services
- Founded
- 2016
- Employees
- 101
- Total raised
- $161.5M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $25.4M · Aug 2024 SEC Form D
- Founders
- Naveen Jain
Viome Acquires Circulate Health to Expand Precision Longevity Platform
Viome Life Sciences has acquired Circulate Health to combine its molecular diagnostics and precision nutrition platform with Circulate’s nationwide clinical network for physician-guided therapeutic plasma exchange, expanding Viome into treatment delivery and forming a new clinical group led by Circulate CEO Brad Younggren, MD.
Vinod Khosla-led Family Agrees to Buy Seattle Seahawks for Reported $9.6 Billion
Veteran venture capitalist Vinod Khosla and his family agreed to buy the Seattle Seahawks from the Paul Allen estate for a reported $9.6 billion; Khosla is a longtime Silicon Valley investor who founded Khosla Ventures and was an early OpenAI backer.
Vinod Khosla Family to Buy Seattle Seahawks for Record $9.6 Billion from Paul Allen Estate
Vinod Khosla and his family agreed to purchase the Seattle Seahawks for a record $9.6 billion from the estate of Paul Allen. Khosla, a prominent Silicon Valley investor with a $15.6 billion net worth, will lead the ownership group with his wife Neeru as controlling owner.
Viome’s Full Body Intelligence Test Discounted to $299 for Amazon Prime Day with Advanced Gut Health Analysis
Viome’s Full Body Intelligence test, offering detailed gut microbiome analysis and personalized food and supplement recommendations, is discounted by $100 during Amazon Prime Day. The test requires at-home collection of blood, saliva, and stool samples and provides comprehensive health insights using advanced RNA sequencing technology.
GeekWire 200 Q2 2025 Lists Top 10 Fast-Growing Pacific Northwest Startups in AI, Robotics, Energy, and More
The GeekWire 200 ranking highlights the fastest-growing private tech startups in the Pacific Northwest, emphasizing innovators in AI, robotics, energy, and more for Q2 2025. This quarterly list, sponsored by JPMorgan Chase, tracks regional tech development and emerging companies.
Viome Raises $25M, Hires Ex-Amazon Exec Kal Raman as COO to Expand CancerDetect Diagnostic
Viome, a microbiome and health diagnostics startup, raised $25 million and hired former Amazon senior VP Kal Raman as COO to expand its diagnostic division. The company’s CancerDetect test for oral and throat cancer, granted FDA breakthrough device status, exhibits high sensitivity and specificity.
Viome Launches Personalized Toothpaste and Gel Leveraging Oral Microbiome Data for $79/Month
Viome, a wellness company, has launched personalized toothpaste and gel products targeting oral health issues using microbiome data from its Oral Health Intelligence test. The MyBiotics system aims to improve dental health by leveraging personalized bacterial insights for a $79 monthly subscription including products and testing.
Viome raises $86.5M Series C and partners with CVS to sell $179 at-home Full Body Intelligence gut test in 200 stores
Seattle-area health tech startup Viome Life Sciences raised an $86.5 million Series C and struck a deal to sell its $179 at-home Full Body Intelligence gut microbiome test in 200 CVS stores and online. Founded by Naveen Jain, Viome analyzes stool, saliva and blood samples and counts investors including Marc Benioff and Khosla Ventures, though some scientists question clinical utility of microbiome kits.
Viome Life Sciences raises $67M Series C to expand at-home gut, immune and cancer screening tests
Bellevue-based Viome Life Sciences raised over $67 million in Series C funding to expand its at-home health screening test business, bringing total capital raised to more than $150 million. Founder and CEO Naveen Jain said the company plans to grow headcount from about 150 to ~200 and will hire more scientists, researchers, and engineers while keeping lab and supplement manufacturing automated.
Viome Raises $67 Million in Latest Funding Round to Expand Microbiome and Diagnostic Testing
Seattle-based microbiome startup Viome Life Sciences has raised $67 million in a new funding round, bringing its total funding to over $125 million. The company offers stool, saliva, and blood testing kits for personalized health insights and is developing an FDA-designated diagnostic test for oral and throat cancer.
Viome raises $54M to develop saliva-based cancer diagnostics and expand microbiome consumer business
Viome Life Sciences raised $54 million to advance cancer diagnostics and support its consumer microbiome testing and customized supplement business, bringing total funding to over $125 million while targeting $100M revenue and one million customers next year.
Nordstrom to sell Viome’s $199 Health Intelligence microbiome test online and in select stores in 2022
Nordstrom will sell Viome Life Sciences’ Viome Health Intelligence microbiome test for $199 online and in select stores in 2022, with the kit requiring a stool sample. Viome sequences RNA to profile gut microbes and offers AI-driven diet/supplement recommendations plus a $149/month supplement service, though its clinical claims rely on non–peer-reviewed data and have drawn outside skepticism.
Former Tech Leaders Join Biotech: Isilon Founder Sujal Patel, Ex-Microsoft Terry Myerson and Others Lead AI-Driven Life Sciences Startups
Several former software and tech executives are moving into biotech and life sciences startups, bringing AI, machine learning, and tech-style business models to companies that analyze proteins, microbes, and medical records. Their tech backgrounds are reshaping product development and funding approaches at firms such as Nautilus Biotechnology, Truveta, insitro and Viome.
Viome Life Sciences splits into Viome Consumer Services and Viome Health Sciences to separate products from diagnostics and therapeutics
Viome, now Viome Life Sciences, has split into two divisions: Viome Consumer Services for individualized diet and supplement products, and Viome Health Sciences to develop diagnostics, predictive biomarkers and therapeutics for chronic disease and cancer. The Bellevue startup, led by CEO Naveen Jain and backed by investors including Marc Benioff, has over 200,000 customers and expects $100 million in revenue next year.
Viome, backed by Marc Benioff, projects $100M revenue next year and hires ex-GSK exec Dr. Emmanuel Hanon
Viome, a Seattle-area microbiome testing and therapeutics startup backed by Marc Benioff, says it has more than 200,000 customers and expects $100 million in revenue next year while hiring Dr. Emmanuel Hanon as global head of R&D to push into vaccines and drugs.
People
-
Brad Younggren Founder, Physician; President, Viome Pro; Co-founder of Circulate
-
Naveen Jain Founder, Executive Officer, Director
